Basic Information
Curocell is developing innovative anticancer drugs using genetically engineered immune cells. Curocell's technology is continuously evolving with the goal of treating various types of cancer. Curocell's OVIS™ technology enhances immune cells to overcome immunosuppression in the tumor microenvironment.
Curocell Inc.
Daejeon,DaejeonMetropolitanCity,SouthKorea
unclear
January 01, 2016
contact@curocellbtx.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios